Ipamorelin 8mg
A synthetic pentapeptide and selective growth hormone secretagogue, designed as a ghrelin receptor (GHSR-1a) agonist. Distinguished from earlier growth hormone releasing peptides by its high selectivity — stimulating GH release without significant concurrent effects on cortisol or prolactin in experimental models. Widely used as a reference compound in GH secretagogue research due to its clean pharmacological profile and well-documented receptor binding characteristics.
For laboratory research use only. Not for human or veterinary use.
Product Overview
Ipamorelin has been extensively referenced in peer-reviewed in-vitro and preclinical literature. Research interest centres on its selective agonism of the growth hormone secretagogue receptor (GHSR-1a), its role in stimulating pulsatile GH release, and its notably clean selectivity profile relative to earlier GHRP compounds. Unlike GHRP-2 and GHRP-6, Ipamorelin does not significantly elevate cortisol or prolactin in experimental models, making it a preferred reference standard in studies designed to isolate GH pathway effects. It is among the most studied selective GH secretagogues in its class, with a well-established body of published data supporting its use in controlled laboratory settings.
Research Use Only
This product is intended solely for laboratory research applications. Not for human or veterinary use. Not for diagnostic or therapeutic use.
